250 related articles for article (PubMed ID: 34936030)
21. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Wik E; Trovik J; Kusonmano K; Birkeland E; Raeder MB; Pashtan I; Hoivik EA; Krakstad C; Werner HM; Holst F; Mjøs S; Halle MK; Mannelqvist M; Mauland KK; Oyan AM; Stefansson IM; Petersen K; Simon R; Cherniack AD; Meyerson M; Kalland KH; Akslen LA; Salvesen HB
Gynecol Oncol; 2014 Sep; 134(3):599-606. PubMed ID: 24995579
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
23. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
24. The role of mesenchymal-epithelial transition in endometrial function.
Owusu-Akyaw A; Krishnamoorthy K; Goldsmith LT; Morelli SS
Hum Reprod Update; 2019 Jan; 25(1):114-133. PubMed ID: 30407544
[TBL] [Abstract][Full Text] [Related]
25. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
[TBL] [Abstract][Full Text] [Related]
26. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
27. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients.
Wang Y; Zhang C
J Clin Lab Anal; 2022 Aug; 36(8):e24560. PubMed ID: 35754147
[TBL] [Abstract][Full Text] [Related]
28. Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Wik E; Ræder MB; Krakstad C; Trovik J; Birkeland E; Hoivik EA; Mjos S; Werner HM; Mannelqvist M; Stefansson IM; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 Mar; 19(5):1094-105. PubMed ID: 23319822
[TBL] [Abstract][Full Text] [Related]
29. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
30. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.
Mirantes C; Espinosa I; Ferrer I; Dolcet X; Prat J; Matias-Guiu X
Hum Pathol; 2013 Oct; 44(10):1973-81. PubMed ID: 23845467
[TBL] [Abstract][Full Text] [Related]
32. Enolase-1 is a therapeutic target in endometrial carcinoma.
Zhao M; Fang W; Wang Y; Guo S; Shu L; Wang L; Chen Y; Fu Q; Liu Y; Hua S; Fan Y; Liu Y; Deng X; Luo R; Mei Z; Jiang Q; Liu Z
Oncotarget; 2015 Jun; 6(17):15610-27. PubMed ID: 25951350
[TBL] [Abstract][Full Text] [Related]
33. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
34. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
Tyszka-Czochara M; Lasota M; Majka M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
[TBL] [Abstract][Full Text] [Related]
35. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
36. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
[TBL] [Abstract][Full Text] [Related]
37. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells.
Liu Y; Wang J; Ni T; Wang L; Wang Y; Sun X
Oncotarget; 2016 May; 7(18):25328-39. PubMed ID: 27015366
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition and cancer stem cells in endometrial cancer.
Supernat A; Lapinska-Szumczyk S; Majewska H; Gulczynski J; Biernat W; Wydra D; Zaczek AJ
Anticancer Res; 2013 Dec; 33(12):5461-9. PubMed ID: 24324082
[TBL] [Abstract][Full Text] [Related]
39. Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent CN; Guttilla Reed IK
Clin Transl Oncol; 2016 Nov; 18(11):1056-1061. PubMed ID: 26856598
[TBL] [Abstract][Full Text] [Related]
40. WNT5A gene and protein expression in endometrial cancer.
Wasniewski T; Kiezun J; Krazinski BE; Kowalczyk AE; Szostak B; Wierzbicki PM; Kiewisz J
Folia Histochem Cytobiol; 2019; 57(2):84-93. PubMed ID: 31198984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
